关注我们
abaloparatide
添加购物车| 名称 | abaloparatide |
|---|---|
| CAS No. | 247062-33-5 |
| 目录号 | ONP20062 |
| 规格 | mg/g/kg |
| 纯度 | ≥98% |
| 价格 | 更多在线询价 |
| 贮存 | -20°C |
| 分子量 | 3961 |
| 序列结构 | AVSEHQLLHDKGKSIQDLRRRELLEKLLXKLHTA |
| 库存 | |
| 产品简述 | Abaloparatide is an analog of PTHrP (parathyroid hormone-related protein). It was approved in April 28, 2017 by the FDA (as Tymlos) for the treatment of postmenopausal women with osteoporosis at high risk for fracture. Abaloparatide is a synthetic peptide that is related to hPTHrP and has demonstrated in preclinical testing the potential to widen the anabolic window for bone therapeutics, stimulating bone formation with a limited effect on bone resorption and mineral mobilization. |